Silvestro Stephen L 4
4 · OptimizeRx Corp · Filed Mar 4, 2025
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Silvestro Stephen L
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-01+1,928→ 121,886 total - Tax Payment
Common Stock
2025-03-01$5.18/sh−572$2,963→ 121,314 total - Exercise/Conversion
Restricted Stock Units
2025-03-01−1,928→ 0 total→ Common Stock (1,928 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
- [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F3]The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.